Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Mar 26, 2020 · 10-K · 86 days after period end · 0001069530-20-000009
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$1.52M | -$678.00K | -$2.42M | -$2.52M |
| EPS Diluted | — | — | — | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 26, 2020 · 86 d after period end
